Abstract
Background
We hypothesized that shunt dysfunction in the ventricular catheter and the shunt valve is caused by different cellular responses. We also hypothesized that the cellular responses depend on different pathophysiological mechanisms.
Methods
Removed shunt material was collected. Macroscopic tissue in the catheters was paraffin-embedded and HE-stained. Valves were incubated with trypsin-EDTA in order to detach macroscopically invisible biomaterial, which was then cytospinned and HE-stained. Associated aetiological and surgical data were collected by reviewing patient files, and ventricular catheter position was examined using preoperative radiology (CT scans).
Results
We examined eleven ventricular catheters and ten shunt valves. Catheters: 6/11 catheters contained intraluminal tissue consisting of vascularised glial tissue and inflammatory cells (macrophages/giant cells and a few eosinophils). Catheter adherence correlated with the presence of intraluminal tissue, and all tissue containing catheters had some degree of ventricle wall contact. All obstructed catheters contained intraluminal tissue, except one catheter that was dysfunctional because of lost ventricular contact. Valves: Regardless of intraoperative confirmation of valve obstruction, all ten valves contained an almost uniform cellular response of glial cells (most likely ependymal cells), macrophages/giant cells, and lymphomonocytic cells. Some degree of ventricle wall catheter contact was present in all examined valves with available radiology (9/10).
Conclusions
The same cellular responses (i.e., glial cells and inflammatory cells) cause both catheter obstruction and valve obstruction. We propose two synergistic pathophysiological mechanisms. (1) Ventricle wall/parenchymal contact by the catheter causes mechanical irritation of the parenchyma including ependymal exfoliation. (2) The shunt material provokes an inflammatory reaction, either nonspecific or specific. In combination, these mechanisms cause obstructive tissue ingrowth (glial and inflammatory) in the catheter and clogging of the valve by exfoliated glial cells and reactive inflammatory cells.
Similar content being viewed by others
References
Aoki N, Sakai T (1990) Avulsion of choroid plexus during revision of ventricular shunting: Its high incidence and predictive value on computed tomography scan. Surg Neurol 33:256–260
Bache S, Petersen JT, Garvey LH (2011) Anaphylaxis to ethylene oxide—a rare and overlooked phenomenon? Acta Anaesthesiol Scand 55:1279–1282
Bierbrauer KS, Storrs BB, McLone DG, Tomita T, Dauser R (1990) A prospective, randomized study of shunt function and infections as a function of shunt placement. Pediatr Neurosurg 16:287–291
Bigner SH, Elmore PD, Dee AL, Johnston WW (1985) The cytopathology of reactions to ventricular shunts. Acta Cytol 29:391–396
Borgbjerg BM, Gjerris F, Albeck MJ, Hauerberg J, Borgesen SE (1995) Frequency and causes of shunt revisions in different cerebrospinal fluid shunt types. Acta Neurochir (Wien) 136:189–194
Browd SR, Gottfried ON, Ragel BT, Kestle JRW (2006) Failure of cerebrospinal fluid shunts. Part II: Overdrainage, loculation, and abdominal complications. Pediatr Neurol 34:171–176
Bruni JE, Del Bigio MR (1986) Reaction of periventricular tissue in the rat fourth ventricle to chronically placed shunt tubing implants. Neurosurgery 19:337–345
Brydon HL, Bayston R, Hayward R, Harkness W (1996) Removed shunt valves: Reasons for failure and implications for valve design. Br J Neurosurg 10:245–251
Brydon HL, Keir G, Thompson EJ, Bayston R, Hayward R, Harkness W (1998) Protein adsorption to hydrocephalus shunt catheters: CSF protein adsorption. J Neurol Neurosurg Psychiatry 64:643–647
Collins P, Hockley AD, Woollam DH (1978) Surface ultrastructure of tissues occluding ventricular catheters. J Neurosurg 48:609–613
Czernicki Z, Strzałkowski R, Walasek N, Gajkowska B (2010) What can be found inside shunt catheters. Acta Neurochir Suppl 106:81–85
Del Bigio MR (1998) Biological reactions to cerebrospinal fluid shunt devices: a review of the cellular pathology. Neurosurgery 42:319–325, discussion 325–316
Del Bigio MR, Bruni JE (1986) Reaction of rabbit lateral periventricular tissue to shunt tubing implants. J Neurosurg 64:932–940
Drake JM, Kestle JR, Milner R, Cinalli G, Boop F, Piatt J, Haines S, Schiff SJ, Cochrane DD, Steinbok P, MacNeil N (1998) Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus. Neurosurgery 43:294–303, discussion 303–295
Ellis MJ, Kazina CJ, Del Bigio MR, McDonald PJ (2008) Treatment of recurrent ventriculoperitoneal shunt failure associated with persistent cerebrospinal fluid eosinophilia and latex allergy by use of an “extracted” shunt. J Neurosurg Pediatr 1:237–239
Franz S, Rammelt S, Scharnweber D, Simon JC (2011) Immune responses to implants—a review of the implications for the design of immunomodulatory biomaterials. Biomaterials 32:6692–6709
Gedikoglu Y, Colak A, Benli K, Erbengi T (1993) Reaction of rabbit lateral periventricular tissue to non-infected and infected (Staphylococcus epidermidis) shunt tubing implants. A light and transmission electron microscope study. Acta Neurochir (Wien) 122:266–270
Go KG, Ebels EJ, van Woerden H (1981) Experiences with recurring ventricular catheter obstructions. Clin Neurol Neurosurg 83:47–56
Goldblum RM, Pelley RP, O’Donell AA, Pyron D, Heggers JP (1992) Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts. Lancet 340:510–513
Gower DJ, Lewis JC, Kelly DL Jr (1984) Sterile shunt malfunction. A scanning electron microscopic perspective. J Neurosurg 61:1079–1084
Guevara JA, La Torre J, Denoya C, Zúccaro G (1981) Microscopic studies in shunts for hydrocephalus. Childs Brain 8:284–293
Harris CA, McAllister JP 2nd (2012) What we should know about the cellular and tissue response causing catheter obstruction in the treatment of hydrocephalus. Neurosurgery 70:1589–1601, discussion 1601–1582
Heidemann SM, Fiore M, Sood S, Ham S (2010) Eosinophil activation in the cerebrospinal fluid of children with shunt obstruction. Pediatr Neurosurg 46:255–258
Koga H, Mukawa J, Nakata M, Sakuta O, Higa Y (1992) Analysis of retained ventricular shunt catheters. Neurol Med Chir (Tokyo) 32:824–828
Kossovsky N, Snow RB (1989) Clinical-pathological analysis of failed central nervous system fluid shunts. J Biomed Mater Res 23:73–86
Lundberg F, Li DQ, Falkenback D, Lea T, Siesjö P, Söderström S, Kudryk BJ, Tegenfeldt JO, Nomura S, Ljungh A (1999) Presence of vitronectin and activated complement factor C9 on ventriculoperitoneal shunts and temporary ventricular drainage catheters. J Neurosurg 90:101–108
Lundberg F, Tegenfeldt JO, Montelius L, Ransjö U, Appelgren P, Siesjö P, Ljungh A (1997) Protein depositions on one hydrocephalus shunt and on fifteen temporary ventricular catheters. Acta Neurochir (Wien) 139:734–742
Luttikhuizen DT, Harmsen MC, Van Luyn MJA (2006) Cellular and molecular dynamics in the foreign body reaction. Tissue Eng 12:1955–1970
Moneret-Vautrin DA, Laxenaire MC, Bavoux F (1990) Allergic shock to latex and ethylene oxide during surgery for spinal bifida. Anesthesiology 73:556–558
Piatt JH, Carlson CV (1993) A search for determinants of cerebrospinal fluid shunt survival: retrospective analysis of a 14-year institutional experience. Pediatr Neurosurg 19:233–241, discussion 242
Pittman T, Kiburz J, Steinhardt G, Krock J, Gabriel K (1995) Ethylene oxide allergy in children with spina bifida. J Allergy Clin Immunol 96:486–488
Pittman T, Williams D, Rathore M, Knutsen AP, Mueller KR (1994) The role of ethylene oxide allergy in sterile shunt malfunctions. Br J Neurosurg 8:41–45
Sainte-Rose C, Piatt JH, Renier D, Pierre-Kahn A, Hirsch JF, Hoffman HJ, Humphreys RP, Hendrick EB (1991) Mechanical complications in shunts. Pediatr Neurosurg 17:2–9
Sekhar LN, Moossy J, Guthkelch AN (1982) Malfunctioning ventriculoperitoneal shunts. Clinical and pathological features. J Neurosurg 56:411–416
Sgouros S, Dipple SJ (2004) An investigation of structural degradation of cerebrospinal fluid shunt valves performed using scanning electron microscopy and energy-dispersive x-ray microanalysis. J Neurosurg 100:534–540
Singh D, Saxena A, Jagetia A, Singh H, Tandon MS, Ganjoo P (2012) Endoscopic observations of blocked ventriculoperitoneal (VP) shunt: a step toward better understanding of shunt obstruction and its removal. Br J Neurosurg
Snow RB, Kossovsky N (1989) Hypersensitivity reaction associated with sterile ventriculoperitoneal shunt malfunction. Surg Neurol 31:209–214
Takahashi Y, Ohkura A, Hirohata M, Tokutomi T, Shigemori M (1998) Ultrastructure of obstructive tissue in malfunctioning ventricular catheters without infection. Neurol Med Chir (Tokyo) 38:399–404, discussion 403–394
Thomale UW, Hosch H, Koch A, Schulz M, Stoltenburg G, Haberl E-J, Sprung C (2010) Perforation holes in ventricular catheters—is less more? Childs Nerv Syst 26:781–789
Traynelis VC, Powell RG, Koss W, Schochet SS, Kaufman HH (1988) Cerebrospinal fluid eosinophilia and sterile shunt malfunction. Neurosurgery 23:645–649
Traynelis VC, Willison CD, Follett KA, Chambers J, Schochet SS Jr, Kaufman HH (1991) Millipore analysis of valvular fluid in sterile valve malfunctions. Neurosurgery 28:848–852
VandeVord PJ, Gupta N, Wilson RB, Vinuya RZ, Schaefer CJ, Canady AI, Wooley PH (2004) Immune reactions associated with silicone-based ventriculo-peritoneal shunt malfunctions in children. Biomaterials 25:3853–3860
Wan KR, Toy JA, Wolfe R, Danks A (2011) Factors affecting the accuracy of ventricular catheter placement. J Clin Neurosci 18:485–488
Wilson TJ, Stetler WR Jr, Al-Holou WN, Sullivan SE (2013) Comparison of the accuracy of ventricular catheter placement using freehand placement, ultrasonic guidance, and stereotactic neuronavigation. J Neurosurg. doi:10.3171/2012.11.JNS111384
Zhong Y, Bellamkonda RV (2008) Biomaterials for the central nervous system. J R Soc Interface 5:957–975
Acknowledgements
Lundbeckfonden; Aase og Ejnar Danielsens Fond; the staff at Laboratory of Neuropathology, Rigshospitalet (Ann Meisler, Jan Lauritzen & Diem Pham).
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Presentation at a conference
Oral presentations at:
International Society for Pediatric Neurosurgery (ISPN) 2012 in Sydney
International Society for Hydrocephalus and Cerebrospinal Fluid Disorders (ISHCSF) 2012 in Kyoto
Clinical Trial Registration number if required
The project was approved by The National Committee on Health Research Ethics (protocol no. H-2-2011-025).
Rights and permissions
About this article
Cite this article
Blegvad, C., Skjolding, A.D., Broholm, H. et al. Pathophysiology of shunt dysfunction in shunt treated hydrocephalus. Acta Neurochir 155, 1763–1772 (2013). https://doi.org/10.1007/s00701-013-1729-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00701-013-1729-6